We confirmed that several IL-17 signaling genes were expressed at a significantly higher level in BM neutrophils stimulated with conditioned medium from intrinsically ICI-sensitive mouse melanoma and that this was abrogated by concurrent α-IL-17A treatment (Fig. 3g). The gene discussed is IL17A; the disease is melanoma.